News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
375,361 Results
Type
Article (23791)
Company Profile (124)
Press Release (351438)
Multimedia
Podcasts (35)
Webinars (14)
Section
Business (121047)
Career Advice (1435)
Deals (20428)
Drug Delivery (78)
Drug Development (34276)
Employer Resources (154)
FDA (6440)
Job Trends (8607)
News (183386)
Policy (13532)
Tag
Academia (1660)
Academic (2)
Accelerated approval (5)
Adcomms (16)
Allergies (36)
Alliances (27394)
ALS (66)
Alzheimer's disease (829)
Antibody-drug conjugate (ADC) (105)
Approvals (6526)
Artificial intelligence (243)
Autoimmune disease (40)
Automation (19)
Bankruptcy (133)
Best Places to Work (6728)
BIOSECURE Act (12)
Biosimilars (81)
Biotechnology (75)
Bladder cancer (61)
Brain cancer (20)
Breast cancer (212)
Cancer (1666)
Cardiovascular disease (161)
Career advice (1240)
Career pathing (36)
CAR-T (125)
CDC (23)
Cell therapy (324)
Cervical cancer (11)
Clinical research (28328)
Collaboration (751)
Compensation (405)
Complete response letters (17)
COVID-19 (1241)
CRISPR (48)
C-suite (439)
Cystic fibrosis (70)
Data (2205)
Decentralized trials (1)
Denatured (23)
Depression (53)
Diabetes (167)
Diagnostics (3730)
Digital health (17)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (107)
Drug pricing (71)
Drug shortages (8)
Duchenne muscular dystrophy (87)
Earnings (49282)
Editorial (27)
Employer branding (23)
Employer resources (136)
Events (60326)
Executive appointments (717)
FDA (7606)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (744)
Gene editing (81)
Generative AI (23)
Gene therapy (217)
GLP-1 (435)
Government (1731)
Guidances (251)
Healthcare (8839)
HIV (30)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (73)
Immuno-oncology (3)
Indications (21)
Infectious disease (1348)
Inflammatory bowel disease (92)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (68)
Interviews (209)
IPO (9911)
IRA (22)
Job creations (2103)
Job search strategy (1065)
Kidney cancer (11)
Labor market (71)
Layoffs (271)
Leadership (22)
Legal (3324)
Liver cancer (40)
Longevity (9)
Lung cancer (218)
Lymphoma (139)
Machine learning (13)
Management (48)
Manufacturing (302)
MASH (64)
Medical device (5867)
Medtech (5878)
Mergers & acquisitions (11089)
Metabolic disorders (440)
Multiple sclerosis (72)
NASH (14)
Neurodegenerative disease (96)
Neuropsychiatric disorders (15)
Neuroscience (1327)
NextGen: Class of 2025 (3332)
Non-profit (2200)
Now hiring (58)
Obesity (212)
Opinion (143)
Ovarian cancer (48)
Pain (76)
Pancreatic cancer (66)
Parkinson's disease (100)
Partnered (19)
Patents (119)
Patient recruitment (129)
Peanut (20)
People (40823)
Pharmaceutical (29)
Pharmacy benefit managers (4)
Phase I (8344)
Phase II (11951)
Phase III (10561)
Pipeline (1738)
Policy (112)
Postmarket research (1075)
Preclinical (3966)
Press Release (71)
Prostate cancer (89)
Psychedelics (26)
Radiopharmaceuticals (144)
Rare diseases (301)
Real estate (3680)
Recruiting (62)
Regulatory (9926)
Reports (50)
Research institute (1445)
Resumes & cover letters (222)
Rett syndrome (12)
RNA editing (6)
RSV (41)
Schizophrenia (85)
Series A (130)
Series B (94)
Service/supplier (8)
Sickle cell disease (36)
Special edition (9)
Spinal muscular atrophy (78)
Sponsored (19)
Startups (2492)
State (1)
Stomach cancer (7)
Supply chain (39)
Tariffs (25)
The Weekly (12)
Vaccines (346)
Venture capital (49)
Weight loss (127)
Women's health (25)
Worklife (17)
Date
Last 7 days (386)
Last 30 days (1322)
Last 365 days (16272)
2025 (13569)
2024 (19329)
2023 (22388)
2022 (29041)
2021 (31552)
2020 (29514)
2019 (24436)
2018 (18176)
2017 (17532)
2016 (16861)
2015 (20003)
2014 (15564)
2013 (12751)
2012 (13740)
2011 (14335)
2010 (13852)
Location
Africa (481)
Alabama (33)
Alaska (5)
Arizona (130)
Arkansas (4)
Asia (20196)
Australia (3260)
California (4882)
Canada (1668)
China (337)
Colorado (213)
Connecticut (245)
Delaware (175)
Europe (47433)
Florida (741)
Georgia (116)
Hawaii (2)
Idaho (30)
Illinois (289)
India (35)
Indiana (296)
Iowa (16)
Japan (206)
Kansas (56)
Kentucky (23)
Louisiana (10)
Maine (52)
Maryland (504)
Massachusetts (3870)
Michigan (168)
Minnesota (261)
Mississippi (3)
Missouri (66)
Montana (18)
Nebraska (19)
Nevada (53)
New Hampshire (27)
New Jersey (1473)
New Mexico (20)
New York (1448)
North Carolina (767)
North Dakota (9)
Northern California (2387)
Ohio (161)
Oklahoma (12)
Oregon (18)
Pennsylvania (858)
Puerto Rico (6)
Rhode Island (27)
South America (623)
South Carolina (21)
Southern California (1778)
Tennessee (89)
Texas (656)
United States (17951)
Utah (129)
Virginia (124)
Washington D.C. (44)
Washington State (401)
West Virginia (3)
Wisconsin (68)
375,361 Results for "exact sciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Exact Sciences Announces Second Quarter 2025 Results
August 7, 2025
·
19 min read
Press Releases
Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests
August 7, 2025
·
5 min read
Press Releases
Exact Sciences to Participate in June Investor Conference
May 27, 2025
·
1 min read
Press Releases
Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer
July 9, 2025
·
4 min read
Press Releases
Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome’s Blood-Based Screening Test for Colorectal Cancer
August 7, 2025
·
6 min read
Press Releases
Exact Sciences Announces First-Quarter 2025 Results
May 1, 2025
·
20 min read
Press Releases
Exact Sciences to Participate in May 2025 Investor Conference
May 2, 2025
·
1 min read
Press Releases
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
May 23, 2025
·
6 min read
Press Releases
Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap
May 28, 2025
·
6 min read
Press Releases
Exact Sciences Schedules First Quarter 2025 Earnings Call
April 1, 2025
·
1 min read
1 of 37,537
Next
